Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Han-Byoel LeeMinsu KimSunyoung KwonJeonghee JoJinkyoung KimHan-Suk RyuChung Yeul KimJaehwan JeongDong-Young NohIn-Ae ParkSei-Hyun AhnSungroh YoonWonshik HanPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
The newly developed and validated NGS-based multigene assay can predict the distant recurrence risk in ER-positive, HER2-negative breast cancer.